Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-02

Clinical Trial Update: Upadacitinib Combined With Corticosteroids vs Corticosteroid Monotherapy Induction for Inpatients and Outpatients With Acute Severe Ulcerative Colitis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing induction with upadacitinib plus corticosteroids versus corticosteroid monotherapy in inpatients and outpatients with acute severe ulcer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Upadacitinib (upadacitinib)

Snippet

Sponsor: Berinstein, Jeffrey | Conditions: Ulcerative Colitis Acute | Phase 4 | Status: RECRUITING